From: Max More (max@maxmore.com)
Date: Sat Dec 18 1999 - 01:02:03 MST
Some of you might be interested to know that the Motley Fool's extremely
well-performing Rule Breaker portfolio (average over 70% per year for five
or six years) has made a very interesting new buy -- Celera, who CEO Craig
Venter appears frequently in the news. Celera is a fascinating
bioinformatics company that is easily beating the government effort to
sequence the human genome (and other genomes) using a unique shotgun approach.
Celera had already been on a tear this month, but today it jumped 13%.
Given it's wonderful combination of computer science and genomics, you
might want to look into them. Here's the Motley Fool's buy report:
http://www.fool.com/portfolios/rulebreaker/trades/rulebreakertrade_cra991216
.htm
Max
This archive was generated by hypermail 2.1.5 : Fri Nov 01 2002 - 15:06:07 MST